当前位置:首页 - 行情中心 - 钱江生化(600796) - 财务分析 - 利润表

钱江生化

(600796)

  

流通市值:18.07亿  总市值:50.61亿
流通股本:3.09亿   总股本:8.67亿

利润表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、营业总收入377,833,176.211,768,342,006.881,300,581,051.6862,661,241.69
营业收入377,833,176.211,768,342,006.881,300,581,051.6862,661,241.69
二、营业总成本353,481,929.541,641,541,816.941,182,695,158.87797,045,559.21
营业成本290,254,708.051,361,719,238.23991,677,142660,882,644.34
税金及附加6,630,675.2116,496,587.410,850,343.77,434,438.36
销售费用2,843,035.0616,084,800.6810,154,155.737,264,153
管理费用30,847,534.52143,703,445.6599,600,472.7968,491,646.52
研发费用7,244,113.8429,825,175.1917,701,048.316,407,747.16
财务费用15,661,862.8673,712,569.7952,711,996.3536,564,929.83
其中:利息费用14,692,785.7285,764,868.4953,327,004.541,464,433.86
其中:利息收入1,266,956.1311,355,292.788,619,062.096,745,150.25
加:投资收益11,243,560.4964,007,272.835,572,440.922,374,940.76
资产处置收益1,966,741.091,145,728.011,149,401.9260,962.83
资产减值损失(新)3,311,992.3-451,618.19-242,029.532,897,390.94
信用减值损失(新)-7,309,673.7-42,736,918.31-20,149,317.29-10,215,583.76
其他收益2,794,097.6115,604,723.8310,063,117.326,770,746.66
营业利润平衡项目0000
四、营业利润36,357,964.46164,369,378.08144,279,506.0587,504,139.91
加:营业外收入63,348.4410,888,985.922,160,711.551,608,266.79
减:营业外支出14,177.87926,092.92781,268.48699,061.42
利润总额平衡项目0000
五、利润总额36,407,135.03174,332,271.08145,658,949.1288,413,345.28
减:所得税费用12,171,723.4648,979,399.2738,360,59522,799,148.6
六、净利润24,235,411.57125,352,871.81107,298,354.1265,614,196.68
持续经营净利润24,235,411.57125,352,871.81107,298,354.1265,614,196.68
归属于母公司股东的净利润30,504,599.36160,003,849.29128,857,967.2582,251,281.43
少数股东损益-6,269,187.79-34,650,977.48-21,559,613.13-16,637,084.75
(一)基本每股收益0.040.180.150.09
(二)稀释每股收益0.040.180.150.09
八、其他综合收益-1,405,515.94--
归属于母公司股东的其他综合收益-1,405,515.94--
九、综合收益总额24,235,411.57126,758,387.75107,298,354.1265,614,196.68
归属于母公司股东的综合收益总额30,504,599.36161,409,365.23128,857,967.2582,251,281.43
归属于少数股东的综合收益总额-6,269,187.79-34,650,977.48-21,559,613.13-16,637,084.75
公告日期2025-04-292025-04-192024-10-292024-08-27
审计意见(境内)标准无保留意见
TOP↑